BAX and liver cancer: Such a polysaccharide develops activity through an apoptosis-associated pathway by modulating the expression of Bax, Bcl-2, and caspase-3 and has been proposed as a potential therapeutic agent (or chemosensitizer) for liver cancer therapy [34].